Histopathology and clinical assessment correlate with the cysteine-serine-valine-threonine-cysteine-glycine (CSVTCG) receptor of thrombospondin-1 in breast tumors

• Roth, J.J. ^[1] ; Reiver, D.M. ^[1] ; Granick, M.S. ^[1] ; Rothman, V.L. ^[1] ; Nicosia, R.F. ^[1] ; Tuszynski, G.P. ^[1]
  1. [1] Allegheny University of the Health Sciences, Medical College of Pennsylvania and Hahnemann School of Medicine, Philadelphia, Pennsylvania, USA
• Localización: Histology and histopathology: cellular and molecular biology, ISSN-e 1699-5848, ISSN 0213-3911, Vol. 12, Nº. 4, 1997, págs. 1013-1018
• Idioma: inglés
• Enlaces
  • Texto completo
• Resumen

  • Thrombospondin-1 (TSP-1) is a matrix protein implicated in mechanisms of tumor metastasis. TSP-1 has a characteristic Cysteine-Serine-Valine- Threonine-Cysteine-Glycine (CSVTCG) sequence that functions as a tumor cell adhesion domain. Our laboratory has isolated a novel CSVTCG specific tumor cell receptor. Immunohistochemical staining techniques and computerized image analysis were used to identify and quantitate the CSVTCG receptor of TSP-1 in a wide spectrum of human archiva1 breast tumors. Histopathologic and quantitative examination was correlated with clinical findings two years post operation. Increasing amounts of CSVTCG receptor correlated positively with worsening histopathologic and clinical findings. These findings suggest a role for the TSP-1 CSVTCG receptor in breast tumor progression. This receptor may have utility for the diagnosis, staging, and treatrnent of this common and deadly disease.